| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |